SECTOR:
Oncology
FUND/VEHICLE:
NFLS Direct Investment
INVESTMENT DATE:
2018
GEOGRAPHY:
North America
STATUS CURRENT/FORMER INVESTMENT:
Former
WEBSITE:
Gossamer Bio is developing multiple candidate products that are designed to modulate the immune system in order to treat the autoimmune diseases and cancers.